LGD1069: Filed IND to start a Phase I/IIa trial

Ligand Pharmaceuticals Inc. (LGNDA), San Diego Product: LGD1069, synthetic retinoid, a class of compounds related to Vitamin A Indication: Oral treatment of cancer Status: Filed IND to start a Phase ...